Intercept Pharmaceuticals, Inc. (ICPT)
Intercept Pharmaceuticals, Inc. (ICPT)
$68.64 USD
Updated Jul 19 12:00am
Add ICPT to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all “A” rated Strong Buy stocks
ICPT News Stream
| Event/Time | News Detail | Start | End | Change | |||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Top Stories View All
Best & Worst Performing Stock Industries for July 19, 2019
Best & Worst Performing Small Cap Stocks for July 19, 2019
Best & Worst Performing Mid Cap Stocks for July 19, 2019
Best & Worst Performing Mega Cap Stocks for July 19, 2019
Best & Worst Performing Large Cap Stocks for July 19, 2019
View All Top StoriesIntercept Pharmaceuticals, Inc. (ICPT) Company Bio
Intercept Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic underserved liver diseases. The company was founded in 2002 and is based in New York, New York.
ICPT Stock Chart More Charts
ICPT Price/Volume Stats
| Current price | $68.64 |
| Prev. close | $71.67 |
| Day low | $68.41 |
| Day high | $72.32 |
| 50-day MA | $80.77 |
| 200-day MA | $98.74 |
| 52-week high | $133.74 |
| 52-week low | $68.19 |
| Volume | 964,100 |
| Avg. volume | 874,038 |
| Dividend yield | N/A |
| Market Cap | 2.04B |
ICPT Returns
| 1-mo | -15.67% |
| 3-mo | -21.11% |
| 6-mo | -38.12% |
| 1-year | -26.82% |
| 3-year | -55.18% |
| 5-year | -69.22% |
| YTD | -31.90% |
| 2018 | 72.53% |
| 2017 | -46.23% |
| 2016 | -27.25% |
| 2015 | -4.26% |
| 2014 | 128.47% |
Loading social stream, please wait...